Dopamine alters CNS migration of uninfected and HIV infected leukocytes to SDF-1
多巴胺改变中枢神经系统未感染和 HIV 感染白细胞向 SDF-1 的迁移
基本信息
- 批准号:8068395
- 负责人:
- 金额:$ 33.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-01 至 2013-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdhesionsAffectAstrocytesAutopsyBehavioralBlood - brain barrier anatomyBrainCD8B1 geneCXCL12 geneCaveolinsCell Adhesion MoleculesCell surfaceCellsChemotaxisChronicClinicalCocaineCognitiveDataDevelopmentDopamineDopamine ReceptorDrug abuseDrug usageEffectivenessEndothelial CellsEpithelial CellsExhibitsExtravasationFunctional disorderHIV-1HealthHighly Active Antiretroviral TherapyHumanImmuneIn VitroIndividualInfectionInfiltrationInflammationIntegrinsLeukocyte ChemotaxisLeukocytesLifeLymphocyteMAPK1 geneMaintenanceMediatingMethamphetamineMethodsMicrogliaMolecularMonkeysMotorNeuraxisNeurocognitiveNeurocognitive DeficitNeurologicNeurologic DysfunctionsNeuronsNeuropathogenesisNodulePhasePhosphorylationPlayPopulationPrevalenceProcessPropertyProteinsReceptor ActivationRecording of previous eventsRegulationReportingRoleSIVSeveritiesSignal PathwaySignal TransductionStromal Cell-Derived Factor 1T cell responseT-LymphocyteTight JunctionsTissuesVascular EndotheliumViral Load resultVirus Diseasescaveolin 1cell motilitychemokinedesigndopamine D4 receptordrug abuserdrug of abuseextracellularin vitro Modelmacrophagemigrationmonocyteneuropsychologicalnon-drugnovelreceptor expressionreceptor-mediated signalingresearch studyresponsetherapy developmenttrafficking
项目摘要
DESCRIPTION (provided by applicant): Although highly active antiretroviral therapy (HAART) has proven effective in treating individuals infected with human immunodeficiency virus 1 (HIV), neuropsychological abnormalities are still major clinical problems of infection. In addition, there are significant numbers of drug abusers in the HIV infected population and many of these individuals have accelerated and more severe neurocognitive dysfunctions when compared to non-drug users infected with HIV. The mechanisms by which drugs of abuse exacerbate neuronal damage in the HIV infected population have not been completely characterized. Some studies have found that drug abuse increases the number of T lymphocytes and monocytes that enter the brain during HIV infection when compared to infected individuals without a history of drug abuse or to non-HIV infected drug abusers. Monocyte entry into the central nervous system (CNS) has been shown to play an important role in the neuropathogenesis of HIV infection. Monocyte, as well as T lymphocyte, influx into the CNS contributes to neuronal damage and the subsequent development of neurocognitive deficits in HIV infected individuals. Thus, characterization of the mechanisms of monocyte and T lymphocyte influx into the CNS would be beneficial in the design of clinical strategies to limit the neurocognitive dysfunctions that occur in HIV infected drug abusers. Many drugs of abuse, including cocaine and methamphetamine, elevate extracellular dopamine levels in the CNS. We have the novel finding that dopamine synergizes with the chemokine CXCL12 (SDF-1) in inducing uninfected human T lymphocyte and monocyte transmigration across an in vitro model of the human blood brain barrier (BBB). In addition, dopamine decreases the expression of the tight junction protein claudin 5 in BBB endothelial cells, a mechanism by which dopamine may decrease the impermeability of the BBB and promote leukocyte transmigration. It is therefore our hypothesis that elevated CNS levels of extracellular dopamine in HIV infected drug abusers exacerbates the infiltration of monocytes and T lymphocytes, both uninfected and HIV infected, into the CNS in response to CXCL12. This leukocyte influx may contribute to enhanced CNS inflammation, BBB disruption, HIV entry and infection of parenchymal cells, and neuronal damage. To address this hypothesis we will; 1) characterize dopamine modulation of CXCL12 induced uninfected and HIV infected T lymphocyte and monocyte transmigration across the BBB and identify the dopamine receptor(s) whose activation contributes to enhanced leukocyte chemotaxis to CXCL12, 2) determine how dopamine receptor(s) activation modulates the chemotactic response of T lymphocytes and monocytes to CXCL12 and how these processes are altered by HIV infection, and 3) analyze the effects of dopamine on the cells of the BBB that may affect CXCL12 induced uninfected and HIV infected T lymphocyte and monocyte transmigration. PUBLIC HEALTH RELEVANCE Neurological problems in HIV infected individuals are increasing in severity, especially if these individuals are also drug abusers. We propose to study how damage to the brain is increased in HIV infected drug abusers. The results of these studies will provide information that would be useful in the development of therapies to treat the neurologic dysfunctions that are major clinical problems in HIV infected drug abusers.
描述(申请人提供):尽管高效抗逆转录病毒疗法(HAART)已被证明对感染人类免疫缺陷病毒1型(HIV)的患者有效,但神经心理异常仍是感染的主要临床问题。此外,在感染艾滋病毒的人群中有相当数量的吸毒者,与感染艾滋病毒的非吸毒者相比,这些人中的许多人的神经认知功能障碍更严重。滥用药物加剧艾滋病毒感染人群神经元损伤的机制尚未完全确定。一些研究发现,与没有吸毒史的感染者或未感染艾滋病毒的吸毒者相比,吸毒增加了艾滋病毒感染期间进入大脑的T淋巴细胞和单核细胞的数量。单核细胞进入中枢神经系统(CNS)在HIV感染的神经发病机制中起重要作用。在HIV感染者中,单核细胞和T淋巴细胞进入中枢神经系统有助于神经元损伤和随后的神经认知障碍的发展。因此,表征单核细胞和T淋巴细胞进入中枢神经系统的机制将有助于临床策略的设计,以限制HIV感染的吸毒者发生的神经认知功能障碍。许多滥用药物,包括可卡因和甲基苯丙胺,会提高中枢神经系统细胞外多巴胺的水平。我们有一个新的发现,多巴胺与趋化因子CXCL12(SDF-1)在诱导未感染的人类T淋巴细胞和单核细胞跨越人血脑屏障(BBB)的体外模型中具有协同作用。此外,多巴胺还可减少血脑屏障内皮细胞紧密连接蛋白claudin 5的表达,这可能是多巴胺降低血脑屏障通透性和促进白细胞迁移的机制之一。因此,我们的假设是,HIV感染的吸毒者中枢神经系统细胞外多巴胺水平的升高加剧了未感染和HIV感染的单核细胞和T淋巴细胞对CXCL12的中枢神经系统的渗透。这种白细胞的流入可能导致中枢神经系统炎症增强、血脑屏障破坏、HIV侵入和实质细胞感染,以及神经元损伤。为了解决这一假说,我们将:1)鉴定多巴胺对CXCL12诱导的未感染和艾滋病毒感染的T淋巴细胞和单核细胞跨血脑屏障的迁移的调节作用,并确定其激活有助于增强白细胞对CXCL12的趋化作用的多巴胺受体(S),2)确定多巴胺受体(S)如何激活调节T淋巴细胞和单核细胞对CXCL12的趋化反应,以及这些过程如何被艾滋病毒感染改变,以及3)分析多巴胺对CXCL12诱导的未感染和艾滋病毒感染的T淋巴细胞和单核细胞迁移的影响。公共卫生相关性艾滋病毒感染者的神经系统问题日益严重,特别是如果这些人也是吸毒者的话。我们建议研究艾滋病毒感染的吸毒者对大脑的损害是如何增加的。这些研究的结果将为开发治疗神经功能障碍提供有用的信息,这些神经功能障碍是艾滋病毒感染的吸毒者的主要临床问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joan Weinberger Berman其他文献
Joan Weinberger Berman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joan Weinberger Berman', 18)}}的其他基金
The impact of methamphetamine on CXCL12 mediated HIV neuropathogenesis
甲基苯丙胺对 CXCL12 介导的 HIV 神经发病机制的影响
- 批准号:
10547875 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别:
Inflammation, BBB disruption, and Reward Function in the Pathogenesis of Depression among PWH
感染者抑郁症发病机制中的炎症、血脑屏障破坏和奖赏功能
- 批准号:
10535898 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别:
The impact of methamphetamine on CXCL12 mediated HIV neuropathogenesis
甲基苯丙胺对 CXCL12 介导的 HIV 神经发病机制的影响
- 批准号:
10666675 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别:
Inflammation, BBB disruption, and Reward Function in the Pathogenesis of Depression among PWH
感染者抑郁症发病机制中的炎症、血脑屏障破坏和奖赏功能
- 批准号:
10707230 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别:
Mechanisms of opioid- mediated HIV neuropathogenesis
阿片类药物介导的 HIV 神经发病机制
- 批准号:
10383747 - 财政年份:2019
- 资助金额:
$ 33.87万 - 项目类别:
Mechanisms of opioid- mediated HIV neuropathogenesis
阿片类药物介导的 HIV 神经发病机制
- 批准号:
9767913 - 财政年份:2019
- 资助金额:
$ 33.87万 - 项目类别:
Mechanisms of opioid- mediated HIV neuropathogenesis
阿片类药物介导的 HIV 神经发病机制
- 批准号:
9919529 - 财政年份:2019
- 资助金额:
$ 33.87万 - 项目类别:
Mechanisms of opioid- mediated HIV neuropathogenesis
阿片类药物介导的 HIV 神经发病机制
- 批准号:
10612386 - 财政年份:2019
- 资助金额:
$ 33.87万 - 项目类别:
Monocyte CNS HIV entry & neurodegeneration: Translational studies in the CART era
单核细胞 CNS HIV 进入
- 批准号:
9915978 - 财政年份:2017
- 资助金额:
$ 33.87万 - 项目类别:
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse
神经辅助药物和阿片类药物滥用中丁丙诺啡对单核细胞的影响
- 批准号:
10618101 - 财政年份:2017
- 资助金额:
$ 33.87万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 33.87万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 33.87万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 33.87万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 33.87万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 33.87万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 33.87万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 33.87万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 33.87万 - 项目类别: